Lauren Orenstein, MD, FAAD
SESSIONS
S033 Hidradenitis Suppurativa/Acne Inversa (HS/AI): Current Medical and Surgical Management
Mar 9, 2024
•
9:00 AM - 12:00 AM
•
Room 6F
DISCLOSURES
HS Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees); MoonLake Immunotherapeutics – Advisory Board(Fees); Novartis – Advisory Board(Fees), Investigator(Grants/Research Funding); Phrase Health – Stockholder(Stock); UCB Pharma – Advisory Board(Fees);